Category: Neurology

Erenumab for Episodic Migraine – The STRIVE Trial

The STRIVE trial introduced Erenumab, a once monthly self injectable drug for prevention of episodic migraine. It’s calcitonin-gene-related peptide (CGRP) antagonist. It is recently approved by...